Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.

[1]  T. W. Smith,et al.  Fatty acid binding protein 4 is expressed in distinct endothelial and non‐endothelial cell populations in glioblastoma , 2012, Neuropathology and applied neurobiology.

[2]  J. Plutzky,et al.  Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway , 2012, Angiogenesis.

[3]  C. Reinero,et al.  The potential use of tyrosine kinase inhibitors in severe asthma , 2012, Current opinion in allergy and clinical immunology.

[4]  S. Berkelhamer,et al.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. , 2011, American journal of respiratory cell and molecular biology.

[5]  Q. Hamid,et al.  Remodeling in asthma. , 2011, The Journal of allergy and clinical immunology.

[6]  H. Hammad,et al.  C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. , 2011, American journal of respiratory and critical care medicine.

[7]  Michele De Palma,et al.  The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. , 2011, The International journal of developmental biology.

[8]  T. Suda,et al.  Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. , 2011, Blood.

[9]  S. Staibano,et al.  Angiogenesis and lymphangiogenesis in bronchial asthma , 2010, Allergy.

[10]  M. Iruela-Arispe,et al.  Extracellular matrix, inflammation, and the angiogenic response. , 2010, Cardiovascular research.

[11]  S. Watkins,et al.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis , 2009, Nature Medicine.

[12]  T. Ince,et al.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Furuhashi,et al.  Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.

[14]  R. Homer,et al.  Developmental regulation of NO-mediated VEGF-induced effects in the lung. , 2008, American journal of respiratory cell and molecular biology.

[15]  B. O'connor,et al.  Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. , 2007, American journal of respiratory and critical care medicine.

[16]  Patty J. Lee,et al.  VEGF‐induced heme oxygenase‐1 confers cytoprotection from lethal hyperoxia in vivo , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  W. Aird.  Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds , 2007, Circulation research.

[18]  J. Liao,et al.  Serveur Académique Lausannois SERVAL serval.unil.ch , 2022 .

[19]  L. Fabbri,et al.  Epithelial damage and angiogenesis in the airways of children with asthma. , 2006, American journal of respiratory and critical care medicine.

[20]  C. Mackay,et al.  The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. , 2006, The Journal of clinical investigation.

[21]  B. Ma,et al.  Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Walters,et al.  Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.

[23]  L. Makowski,et al.  The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis , 2005, Current opinion in lipidology.

[24]  J. Suttles,et al.  The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.

[25]  E. Wagner,et al.  Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[26]  J. Suttles,et al.  The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. , 2005, The Journal of biological chemistry.

[27]  Wayne Mitzner,et al.  Vascular remodeling in the circulations of the lung. , 2004, Journal of applied physiology.

[28]  D. McDonald,et al.  Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. , 2004, The American journal of pathology.

[29]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[30]  D. McDonald,et al.  Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.

[31]  Q. Hamid,et al.  Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. , 2001, The Journal of allergy and clinical immunology.

[32]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[33]  N. Aoike,et al.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.

[34]  W. Mitzner,et al.  Angiogenesis in the mouse lung. , 2000, The American journal of pathology.

[35]  D. Bernlohr,et al.  The Mammalian Fatty Acid-binding Protein Multigene Family: Molecular and Genetic Insights into Function , 2000, Trends in Endocrinology & Metabolism.

[36]  J. Wilson.  The bronchial microcirculation in asthma. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[37]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[38]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[39]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[40]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.